Clinical Trial
[Tranexamic acid in the prevention of oropharyngeal radiomucositis]
[Article in
Italian]
- PMID: 6658041
Item in Clipboard
Clinical Trial
[Tranexamic acid in the prevention of oropharyngeal radiomucositis]
[Article in
Italian]
Radiol Med.
1983 May.
Abstract
The therapeutic effect of tranexamic acid in prevention of radiomucositis has been evaluated in a double blind study. The results suggest that tranexamic acid can be the useful for the treatment of radiomucositis in head and neck cancer patients submitted to radiotherapy.
Similar articles
-
[Controlled clinical study of tranexamic acid in the treatment of inflammatory otorhinolaryngological diseases].Clin Ter. 1981 Feb 15;96(3):251-61. Clin Ter. 1981. PMID: 7030581 Clinical Trial. Italian. No abstract available.
-
Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study.Acta Derm Venereol. 1977;57(4):369-70. Acta Derm Venereol. 1977. PMID: 70935 Clinical Trial.
-
Efficacy of prophylactic application of immunoglobulins in radiation induced mucositis.Strahlenther Onkol. 1995 Jul;171(7):415-6. Strahlenther Onkol. 1995. PMID: 7631264 Clinical Trial. English, German. No abstract available.
-
Management of oral health in patients irradiated for head and neck cancer: a review.Kathmandu Univ Med J (KUMJ). 2007 Jan-Mar;5(1):117-20. Kathmandu Univ Med J (KUMJ). 2007. PMID: 18604001 Review.
-
Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.Curr Opin Oncol. 2006 May;18(3):266-70. doi: 10.1097/01.cco.0000219256.37843.83. Curr Opin Oncol. 2006. PMID: 16552239 Review.
Cited by
-
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.Cochrane Database Syst Rev. 2016 Mar 15;3(3):CD009733. doi: 10.1002/14651858.CD009733.pub3. Cochrane Database Syst Rev. 2016. PMID: 26978005 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical